Syros Pharmaceuticals (SYRS) Q4 2024 Earnings

Oct 31Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-2.18
-1.49
-0.79
-0.1

Details

Expected EPS
-0.67628
Actual EPS
-0.16
Surprise EPS
0.52
Surprise Percent
+76.34%

Description

⁨Syros Pharmaceuticals⁩ (⁦SYRS⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts